Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR2 | P21452 | 3/20 | 0.57 |
| ▸ | TACR3 | P29371 | 9/20 | 0.48 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.42 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.42 |
| ▸ | TACR1 | P25103 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15190174 | 0.94 | TACR2 (0.52) | TACR2TACR3SIGMAR1OPRM1TACR1 | |
| SCHEMBL1381405 | 0.92 | TACR2 (0.50) | TACR2TACR3TACR1 | |
| SCHEMBL1384573 | 0.90 | TACR2 (0.51) | TACR2TACR3TACR1 | |
| SCHEMBL1381888 | 0.89 | TACR1 (0.52) | TACR2TACR3TACR1 | |
| SCHEMBL4630862 | 0.87 | TACR2 (0.56) | TACR2TACR3TACR1 | |
| SCHEMBL1381258 | 0.87 | TACR3 (0.52) | TACR2TACR3TACR1 | |
| SCHEMBL1384598 | 0.86 | TACR3 (0.51) | TACR2TACR3TACR1 | |
| SCHEMBL1382624 | 0.86 | TACR2 (0.45) | TACR2TACR3TACR1CYP2C19 | |
| Hydrochloric Acid SCHEMBL7744601 | 0.86 | TACR2 (0.55) | TACR2TACR3TACR1 | |
| Hydrochloric Acid SCHEMBL7744599 | 0.86 | TACR2 (0.55) | TACR2TACR3TACR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1773823-B1 | 4-ARYLMORPHOLIN-3-ONE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF | SANOFI SA (FR) | 2013-08-21 | — | — | EP | claimed |
| JP-4812759-B2 | — | — | 2011-11-09 | — | — | JP | claimed |
| EP-1773823-A1 | 4-ARYLMORPHOLIN-3-ONE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF | Sanofi-Aventis (FR) | 2007-04-18 | — | — | EP | claimed |
| WO-2006021654-A1 | 4-ARYLMORPHOLIN-3-ONE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF | SANOFI-AVENTIS (FR) | 2006-03-02 | — | — | WO | claimed |
| EP-1773823-B1 | 4-ARYLMORPHOLIN-3-ONE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF | SANOFI SA (FR) | 2013-08-21 | — | — | EP | disclosed |
| EP-1773823-A1 | 4-ARYLMORPHOLIN-3-ONE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF | Sanofi-Aventis (FR) | 2007-04-18 | — | — | EP | disclosed |
| WO-2006021654-A1 | 4-ARYLMORPHOLIN-3-ONE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF | SANOFI-AVENTIS (FR) | 2006-03-02 | — | — | WO | disclosed |